Filed: 11/14/2023ACC: 0001012975-23-000467
📋 What this filing means
EUCLIDEAN CAPITAL LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $458.13M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$458.13M
Total AUM (reported)
23.94M
Total Shares
Allocation by class
GOLD SHS$182.17M39.8%
MSCI INDIA ETF$107.24M23.4%
TR UNIT$105.27M23.0%
COM$53.44M11.7%
CLASS A COM$10.01M2.2%
Portfolio Concentration
Top 3$394.67M86.1%
4–10$62.00M13.5%
11–25$1.46M0.3%
Top 3 weight
86.1%
Top 10 weight
99.7%
Voting Authority Distribution
Total shares with voting rights: 23.94M
Sole
Full voting authority
23.94M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
SPDR GOLD TR
SOLEShares1.06M
TypeSH
Market value$182.17M
39.76%
Sole
1.06M
Shared
0.00
None
0.00
ISHARES TR
SOLEShares2.43M
TypeSH
Market value$107.24M
23.41%
Sole
2.43M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares246.25K
TypeSH
Market value$105.27M
22.98%
Sole
246.25K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares2.63M
TypeSH
Market value$16.13M
3.52%
Sole
2.63M
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares657.90K
TypeSH
Market value$10.93M
2.39%
Sole
657.90K
Shared
0.00
None
0.00
23ANDME HOLDING CO
SOLEShares10.24M
TypeSH
Market value$10.01M
2.19%
Sole
10.24M
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares1.31M
TypeSH
Market value$8.47M
1.85%
Sole
1.31M
Shared
0.00
None
0.00
FOGHORN THERAPEUTICS INC
SOLEShares1.57M
TypeSH
Market value$7.87M
1.72%
Sole
1.57M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares989.41K
TypeSH
Market value$5.99M
1.31%
Sole
989.41K
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares1.02M
TypeSH
Market value$2.59M
0.57%
Sole
1.02M
Shared
0.00
None
0.00
NGM BIOPHARMACEUTICALS INC
SOLEShares992.17K
TypeSH
Market value$1.06M
0.23%
Sole
992.17K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares802.96K
TypeSH
Market value$393.5K
0.09%
Sole
802.96K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR GOLD TRSOLE | GOLD SHS | 1.06M | SH | $182.17M 39.76% | 1.06M | 0.00 | 0.00 |
ISHARES TRSOLE | MSCI INDIA ETF | 2.43M | SH | $107.24M 23.41% | 2.43M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 246.25K | SH | $105.27M 22.98% | 246.25K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 2.63M | SH | $16.13M 3.52% | 2.63M | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 657.90K | SH | $10.93M 2.39% | 657.90K | 0.00 | 0.00 |
23ANDME HOLDING COSOLE | CLASS A COM | 10.24M | SH | $10.01M 2.19% | 10.24M | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 1.31M | SH | $8.47M 1.85% | 1.31M | 0.00 | 0.00 |
FOGHORN THERAPEUTICS INCSOLE | COM | 1.57M | SH | $7.87M 1.72% | 1.57M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 989.41K | SH | $5.99M 1.31% | 989.41K | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 1.02M | SH | $2.59M 0.57% | 1.02M | 0.00 | 0.00 |
NGM BIOPHARMACEUTICALS INCSOLE | COM | 992.17K | SH | $1.06M 0.23% | 992.17K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM | 802.96K | SH | $393.5K 0.09% | 802.96K | 0.00 | 0.00 |